These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2685487)

  • 1. Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates.
    Skolnick P; Marvizón JC; Jackson BW; Monn JA; Rice KC; Lewin AH
    Life Sci; 1989; 45(18):1647-55. PubMed ID: 2685487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex.
    Marvizón JC; Lewin AH; Skolnick P
    J Neurochem; 1989 Mar; 52(3):992-4. PubMed ID: 2465385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.
    Lehmann J; Hutchison AJ; McPherson SE; Mondadori C; Schmutz M; Sinton CM; Tsai C; Murphy DE; Steel DJ; Williams M
    J Pharmacol Exp Ther; 1988 Jul; 246(1):65-75. PubMed ID: 2899170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
    J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.
    Singh L; Donald AE; Foster AC; Hutson PH; Iversen LL; Iversen SD; Kemp JA; Leeson PD; Marshall GR; Oles RJ
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):347-51. PubMed ID: 2153294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.
    Rostock A; Tober C; Rundfeldt C; Bartsch R; Engel J; Polymeropoulos EE; Kutscher B; Löscher W; Hönack D; White HS; Wolf HH
    Epilepsy Res; 1996 Apr; 23(3):211-23. PubMed ID: 8739124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors.
    Trullas R; Jackson B; Skolnick P
    Pharmacol Biochem Behav; 1989 Oct; 34(2):313-6. PubMed ID: 2576136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strychnine-insensitive glycine receptors in embryonic chick retina: characteristics and modulation of NMDA neurotoxicity.
    Boje KM; Skolnick P; Raber J; Fletcher RT; Chader G
    Neurochem Int; 1992 Jun; 20(4):473-86. PubMed ID: 1339019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuously infused 2-amino-7-phosphonoheptanoic acid antagonizes N-methyl-D-aspartate-induced elevations of cyclic GMP in vivo in multiple brain areas and chemically-induced seizure activity.
    McCaslin PP; Morgan WW
    Neuropharmacology; 1986 Aug; 25(8):905-9. PubMed ID: 2877414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
    Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of strychnine-insensitive glycine binding with MK-801 binding in brain synaptic membranes.
    Yoneda Y; Ogita K; Suzuki T
    J Neurochem; 1990 Jul; 55(1):237-44. PubMed ID: 2192015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
    Witkin JM; Gasior M; Heifets B; Tortella FC
    J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
    Nowak G; Trullas R; Layer RT; Skolnick P; Paul IA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1380-6. PubMed ID: 8099620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
    Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
    Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strychnine-insensitive binding of [3H]glycine to synaptic membranes in rat brain, treated with Triton X-100.
    Ogita K; Suzuki T; Yoneda Y
    Neuropharmacology; 1989 Nov; 28(11):1263-70. PubMed ID: 2687715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioligand labeling of N-methyl-D-aspartic acid (NMDA) receptors by [3H](+-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in brain synaptic membranes treated with Triton X-100.
    Yoneda Y; Ogita K; Kouda T; Ogawa Y
    Biochem Pharmacol; 1990 Jan; 39(1):225-8. PubMed ID: 2153381
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
    Mount H; Quirion R; Chaudieu I; Boksa P
    Mol Pharmacol; 1991 Feb; 39(2):205-10. PubMed ID: 1825345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
    Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.
    Fossom LH; Basile AS; Skolnick P
    Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.